Analyst price target range
REGENXBIO Price Target: $21.40 Average
Direct answer
REGENXBIO's average price target is $21.40.
The verified analyst range runs from $12.00 to $42.00.
The low target implies +49.4%, the high target implies +423%, and the range spans 373.6% of the current price.
Forecast evidence checked November 13, 2026.
Get free REGENXBIO email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $8.03
- Average price target
- $21.40
- High price target
- $42.00
- Low price target
- $12.00
- Low target gap
- +49.4%
- Target upside
- +166.5%
- High target gap
- +423%
- Target range width
- 373.6%
- Consensus rating
- Strong Buy
- Analysts
- 10
- Evidence date
- November 13, 2026
- Valid through
- November 20, 2026
Explore related company data
Read the frequently asked questions.
What is REGENXBIO's average price target?
REGENXBIO's verified average price target is $21.40. The target range is $12.00 to $42.00.
How far are REGENXBIO's low and high targets from the recorded price?
The low target implies +49.4%, while the high target implies +423%.
How many analysts are included in REGENXBIO's consensus?
The verified consensus includes 10 analysts.
How is REGENXBIO's target upside or downside calculated?
The average target of $21.40 is divided by the recorded price of $8.03, then one is subtracted to produce +166.5%. This does not guarantee a future return.
When was REGENXBIO's analyst forecast verified?
The data was verified on 2026-11-13. The dataset is valid through 2026-11-20.